Class information for: |
Basic class information |
| ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
|---|---|---|---|
| 1355 | 2606 | 41.9 | 79% |
Classes in level above (level 2) |
Terms with highest relevance score |
| Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|---|
| 1 | OXIDIZED LDL | Author keyword | 49 | 21% | 8% | 209 |
| 2 | LOW DENSITY LIPOPROTEIN | Author keyword | 32 | 12% | 9% | 241 |
| 3 | LIPOPROTEIN OXIDATION | Author keyword | 23 | 40% | 2% | 46 |
| 4 | LDL OXIDATION | Author keyword | 23 | 20% | 4% | 103 |
| 5 | OXIDIZED LOW DENSITY LIPOPROTEIN | Author keyword | 22 | 18% | 4% | 113 |
| 6 | PROBUCOL | Author keyword | 13 | 17% | 3% | 70 |
| 7 | COPPER INDUCED OXIDATION | Author keyword | 13 | 69% | 0% | 11 |
| 8 | SERUM OXIDATION | Author keyword | 12 | 86% | 0% | 6 |
| 9 | PEROXIDIZED LOW DENSITY LIPOPROTEIN | Author keyword | 11 | 100% | 0% | 6 |
| 10 | TOCOPHEROL MEDIATED PEROXIDATION | Author keyword | 11 | 78% | 0% | 7 |
Web of Science journal categories |
Author Key Words |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
|---|---|---|---|---|---|---|---|
| 1 | OXIDIZED LDL | 49 | 21% | 8% | 209 | Search OXIDIZED+LDL | Search OXIDIZED+LDL |
| 2 | LOW DENSITY LIPOPROTEIN | 32 | 12% | 9% | 241 | Search LOW+DENSITY+LIPOPROTEIN | Search LOW+DENSITY+LIPOPROTEIN |
| 3 | LIPOPROTEIN OXIDATION | 23 | 40% | 2% | 46 | Search LIPOPROTEIN+OXIDATION | Search LIPOPROTEIN+OXIDATION |
| 4 | LDL OXIDATION | 23 | 20% | 4% | 103 | Search LDL+OXIDATION | Search LDL+OXIDATION |
| 5 | OXIDIZED LOW DENSITY LIPOPROTEIN | 22 | 18% | 4% | 113 | Search OXIDIZED+LOW+DENSITY+LIPOPROTEIN | Search OXIDIZED+LOW+DENSITY+LIPOPROTEIN |
| 6 | PROBUCOL | 13 | 17% | 3% | 70 | Search PROBUCOL | Search PROBUCOL |
| 7 | COPPER INDUCED OXIDATION | 13 | 69% | 0% | 11 | Search COPPER+INDUCED+OXIDATION | Search COPPER+INDUCED+OXIDATION |
| 8 | SERUM OXIDATION | 12 | 86% | 0% | 6 | Search SERUM+OXIDATION | Search SERUM+OXIDATION |
| 9 | PEROXIDIZED LOW DENSITY LIPOPROTEIN | 11 | 100% | 0% | 6 | Search PEROXIDIZED+LOW+DENSITY+LIPOPROTEIN | Search PEROXIDIZED+LOW+DENSITY+LIPOPROTEIN |
| 10 | TOCOPHEROL MEDIATED PEROXIDATION | 11 | 78% | 0% | 7 | Search TOCOPHEROL+MEDIATED+PEROXIDATION | Search TOCOPHEROL+MEDIATED+PEROXIDATION |
Key Words Plus |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | OXIDATIVE MODIFICATION | 87 | 23% | 13% | 338 |
| 2 | HERITABLE HYPERLIPIDEMIC RABBIT | 86 | 36% | 7% | 189 |
| 3 | LDL | 77 | 16% | 17% | 441 |
| 4 | ENHANCED MACROPHAGE DEGRADATION | 49 | 55% | 2% | 62 |
| 5 | INVITRO OXIDATION | 46 | 41% | 3% | 88 |
| 6 | ULTRAVIOLET TREATED LIPOPROTEINS | 36 | 79% | 1% | 23 |
| 7 | PROBUCOL | 22 | 23% | 3% | 86 |
| 8 | INDEPENDENT OXIDATION | 21 | 73% | 1% | 16 |
| 9 | OXIDATIVELY MODIFIED LDL | 21 | 46% | 1% | 33 |
| 10 | TOCOPHEROL MEDIATED PEROXIDATION | 20 | 40% | 1% | 38 |
Journals |
Reviews |
| Title | Publ. year | Cit. | Active references | % act. ref. to same field |
|---|---|---|---|---|
| The role of oxidized lipoproteins in atherogenesis | 1996 | 972 | 219 | 40% |
| Analysis of the kinetics of lipid peroxidation in terms of characteristic time-points | 2014 | 5 | 40 | 88% |
| The oxidative modification hypothesis of atherogenesis: An overview | 2000 | 459 | 122 | 44% |
| THE ROLE OF LIPID-PEROXIDATION AND ANTIOXIDANTS IN OXIDATIVE MODIFICATION OF LDL | 1992 | 1825 | 245 | 61% |
| Measurement of plasma oxidized low-density lipoprotein and its clinical implications | 2007 | 60 | 54 | 63% |
| ATHEROSCLEROSIS - BASIC MECHANISMS - OXIDATION, INFLAMMATION, AND GENETICS | 1995 | 1135 | 100 | 33% |
| Role of oxidative modifications in atherosclerosis | 2004 | 1189 | 1022 | 14% |
| Oxidants and antioxidants in the pathogenesis of atherosclerosis: implications for the oxidized low density lipoprotein hypothesis | 1998 | 324 | 137 | 45% |
| The oxidative modification hypothesis of atherosclerosis: Does it hold for humans? | 2001 | 258 | 95 | 49% |
| Atherogenesis in perspective: Hypercholesterolemia and inflammation as partners in crime | 2002 | 388 | 80 | 24% |
Address terms |
| Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | IMUNOFISIOPATOL | 3 | 57% | 0.2% | 4 |
| 2 | HLTH EXERCISE | 3 | 30% | 0.3% | 8 |
| 3 | IMMUNOPHYSIOPATHOL | 3 | 50% | 0.2% | 4 |
| 4 | BIOCHIM METAB CLIN | 3 | 23% | 0.4% | 10 |
| 5 | MCA | 2 | 14% | 0.6% | 15 |
| 6 | GEN INTERNAL MED 564 | 2 | 67% | 0.1% | 2 |
| 7 | GLAXO S | 2 | 67% | 0.1% | 2 |
| 8 | LIPID METAB GRP | 2 | 67% | 0.1% | 2 |
| 9 | MICROBIOL MOL PATHOL | 2 | 19% | 0.3% | 9 |
| 10 | OLIPOPROT UNIT | 2 | 31% | 0.2% | 5 |
Related classes at same level (level 1) |
| Rank | Relatedness score | Related classes |
|---|---|---|
| 1 | 0.0000258766 | ELECTRONEGATIVE LDL//ELECTRONEGATIVE LOW DENSITY LIPOPROTEIN//ENZYMATICALLY MODIFIED LDL |
| 2 | 0.0000220150 | PROBUCOL//AGI 1067//SUCCINOBUCOL |
| 3 | 0.0000147621 | ANTIHYPERCHOLESTEROLEMIC EFFECT//ETIOL EPIDEMIOLMINIST HLTH 23618104//FISIOL FARMACOL VASC |
| 4 | 0.0000142968 | SCAVENGER RECEPTOR//FRACTIONATED H 3HEPARIN//CLASS A SCAVENGER RECEPTOR |
| 5 | 0.0000117154 | ANTIOXIDANT VITAMINS//PREVENTION TRIAL//CELL METAB NUTR |
| 6 | 0.0000115697 | AGE RELATED DECREASE IN PGI2 PRODUCTION//EN FACE TECHNIQUE//15 ISOPROSTANE F 2T |
| 7 | 0.0000110557 | LYSOPHOSPHATIDYLCHOLINE//G2A//TDAG8 |
| 8 | 0.0000091635 | TRANSGENES CARDIOVASC CONTROL//SILICONE COLLAR//WHHL RABBIT |
| 9 | 0.0000089572 | VASCULAR DENDRITIC CELLS//MOL MED CEMM//OPPENHEIMER ATHEROSCLEROSIS |
| 10 | 0.0000089425 | LOX 1//LECTIN LIKE OXIDIZED LOW DENSITY LIPOPROTEIN RECEPTOR 1//LOX 1 RECEPTOR |